Genomics BioSci & Tech Co., Ltd. (4195)
Market Closed
10 Jul, 05:30
TWSE TWSE Primary NT$
17. 85
0
0%
NT$
1.35B Market Cap
- P/E Ratio
- Div Yield
553,001 Volume
- Eps
NT$ 17.85
Previous Close Want to track 4195 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Genomics BioSci & Tech Co., Ltd. (4195) Statistics
Valuation metrics
Market Cap 1.35B
Enterprise value 2.83B
Trailing P/E (ttm) -54.54
Forward P/E -
PEG ratio -0.45
Price/Sales (ttm) 3.33
Price/Book (mrq) 4.18
Enterprise Value/Revenue 3.99
Enterprise Value/EBITDA -337.32
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 254.11K
Average volume (90 days) 454.14K
Price summary
52-Week low 15.1
52-Week high 36.85
Beta -
50-Day moving average 16.4
200-Day moving average 22.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,020:1,000
Last split Date 8 Aug 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.06%
Operating margin -0.12%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 9.78
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.75
Total debt (mrq) -
Total Debt/Equity (mrq) 1.23
Current ratio (mrq) 1.2%
Book value per share (mrq) 8.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
